Investor pushes Stallergenes to merge with U.S. partner; Polish drug market growing fast;

@FiercePharma: Pfizer shuttering vitamin C plant in California, 70 workers out of jobs. FiercePharmaManufacturing story | Follow @FiercePharma

@EricPFierce: UK starts on $85M cell manufacturing facility as report shows country has become net importer of drugs. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Merck's Rebif held its own in last year's MS market shakeup. What about 2015? More | Follow @CarlyHFierce

> The controlling shareholder in allergy drug specialist Stallergenes has proposed merging with its U.S. partner Greer to create a company with combined sales of €330 million, or about $368 million. Report

> The Polish drug market grew to €6.5 billion in 2014, with almost half of that spent on over-the-counter remedies. Report

> India's Sun Pharma bought GlaxoSmithKline's ($GSK) opiates business in Australia, a move that put Sun in charge of a quarter of the world's opiate supply, derived from poppies grown in the states of Tasmania and Victoria. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: Nevro appoints former JJDC head to board as it awaits anticipated FDA approval. Article | Follow @FierceMedDev

@VarunSaxena2: FDA requires new labeling on insulin pens to ward off spread of infections. More from FierceDrugDelivery | Follow @VarunSaxena2

@EmilyWFierce: Pharma CMO? Meet your CIO--and start working together already. FiercePharmaMarketing article | Follow @EmilyWFierce

> Studies show need to supplement mammography with MRI, ultrasound for dense breast tissue. News

> Intuitive Surgical returns to the battlefield with $430M DOD contract. Article

> S&N falls on Stryker buyback plan, buys into Latin American distributor. Story

Biotech News

@FierceBiotech: Scripps investigators ID a key player in disarming chemotherapy. FierceBiotechResearch story | Follow @FierceBiotech

@JohnCFierce: Bristol-Myers forges a billion-dollar cancer vaccine deal with Bavarian Nordic. News | Follow @JohnCFierce

@DamianFierce: Alkahest, a @JNJInnovation incuabatee, signed a $50M deal with Grifols. Release | Follow @DamianFierce

> Warp Drive recruits an Alnylam vet to take the reins. Item

> As split looms, Baxter bags autoimmune biotech SuppreMol for $225M. Story

> Startup Alkahest inks a $50M deal for anti-aging R&D. Article

> Genfit is next up in the M&A rumor mill thanks to its NASH drug. Report

Drug Delivery News

> Chrono Therapeutics ropes in new funds from Rock Health for smoking cessation device. Story

> Forbes gives drug delivery a shoutout, says it can make good drugs great. Item

> FDA requires new labeling on insulin pens to ward off spread of infections. Article

> Amgen launches delivery device for automatic administration of its blockbuster Neulasta. News

> Evidence that inhaled oxytocin improves social behavior among autistic patients spurs R&D. More

Diagnostics News

> FDA grants emergency use authorization to Corgenix's fast-acting Ebola diagnostic. Article

> RainDance waltzes toward $60M IPO. News

> Skin test could vastly simplify diagnosis of Alzheimer's and Parkinson's. More

> Exact Sciences beefs up sales and reimbursement efforts for colon cancer Dx. Story

> Vigilant Biosciences reels in $5.5M for oral cancer test. Report

Pharma Marketing News

> The long, strange story of Cubist's Cards Against Biotechnology. Feature

> Goldman cuts Afrezza sales forecast in half on slow uptake, pricing pressure. Report

> Surprise: Obesity med Contrave might help CV outcomes. Too bad Orexigen blabbed it. More

> The PD-1 wave? Report says it's a $33B tsunami, with BMS surfing for first place. Story

> Pharma CMO? Meet your CIO--and start working together already. Article

And Finally... Elderly people with cognitive problems may suffer faster decline if their blood pressure is too tightly controlled with drugs. Report